Future opportunities for probiotic innovation lie within combination ingredients, precision nutrition, and next-gen strains, according to Dr. Johanna Maukonon, director of global clinical innovation at IFF Health.
Individual assessments could be used to design ‘precision nutrition’ in relation to self-reported dietary and lifestyle habits and anthropometric data, combined with a patient’s genetic profile and gut status.
